Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 10, 2010 09:00 ET | Source: StemCells, Inc.

StemCells, Inc. Announces First Human Neural Stem Cell Transplant in Landmark Myelination Disorder Trial

PALO ALTO, Calif., Feb. 10, 2010 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM) announced today that its proprietary HuCNS-SC® human neural stem cells have been used to treat the first patient...